首页> 外国专利> A COMPOSITION COMPRISING CHINESE TRADITIONAL MEDICINE AS ACTIVE INGREDIENT FOR TREATING CARDIOVASCULAR DISEASES AND QUALITY CONTROL METHOD THEREOF

A COMPOSITION COMPRISING CHINESE TRADITIONAL MEDICINE AS ACTIVE INGREDIENT FOR TREATING CARDIOVASCULAR DISEASES AND QUALITY CONTROL METHOD THEREOF

机译：一种中药为治疗心血管疾病的有效成分的组合物及其质量控制方法

页面导航

摘要
著录项
相似文献

摘要

A Danqi composition comprising the ingredients as followed: (a) 0.7-4.3 parts by weight of ginsenoside Rg1; (b) 1.0 parts by weight of salvianolic acid B; (c) 0.7-4.3 parts by weight of ginsenoside Rb1. A quality control method of Danqi composition comprising controlling ginsenoside Rg1 : salvianolic acid B : ginsenoside Rb1=0.7-4.3 : 1 : 0.7-4.3 in Danqi composition. The main ingredients for treating cardiovascular diseases effectively and preferred ratio thereof in red sage root and notoginseng as essential ingredients in Danqi formulation are disclosed for the first time. The range of ratio makes it conveniently that control the content of ingredient when the Danqi formulation is prepared to obtain preferably therapeutic effect, which solves the problem that the therapeutic effect is dissatisfactory as a result of the main active ingredients and content thereof being unknown when the Danqi formulation is prepared in the past.

机译：一种丹奇组合物，其包含以下成分：（a）0.7-4.3重量份的人参皂苷Rg1; （b）1.0重量份丹酚酸B; （c）0.7-4.3重量份的人参皂甙Rb1。丹参组合物的质量控制方法，包括控制丹参组合物中的人参皂苷Rg1：丹酚酸B：人参皂苷Rb1 ＝ 0.7-4.3∶1∶0.7-4.3。丹参制剂中首次公开了有效治疗心血管疾病的主要成分及其在丹参和三七中的优选比例作为基本成分。比率的范围使得在制备丹奇制剂时方便地控制成分的含量以获得优选的治疗效果，解决了由于主要活性成分及其含量未知时治疗效果不理想的问题。丹奇制剂是过去制备的。

著录项

公开/公告号WO2008064592A1

专利类型
公开/公告日2008-06-05

原文格式PDF
申请/专利权人 SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES;GUO DEAN;WU WANYING;GAO ZHIGANG;
展开▼

申请/专利号WO2007CN70811
发明设计人 GUO DEAN;WU WANYING;GAO ZHIGANG;
展开▼

申请日2007-09-28
分类号A61K31/704;A61K31/343;A61K9/20;A61K9/08;A61K9/19;A61K9/16;A61K9/48;G01N30;G01N30/02;G01N21;A61P9/10;A61P9;
国家 WO
入库时间 2022-08-21 19:59:06

相似文献

专利
外文文献
中文文献